In this week’s Video Forum, Todd Huseby, a partner at consulting firm Kearney and leader of the company’s consumer health care practice, examines trends currently shaping the industry and their relation to developments in the broader economy. Among the issues that Huseby addresses are the high cost of health care, its impact on community pharmacy operators, and the rapid emergence of new business models.
Video Forum: Todd Huseby, Kearney, Part 1
In this week’s Video Forum, Todd Huseby, a partner at consulting firm Kearney and leader of the company’s consumer health care practice, examines trends currently shaping the industry and their relation to developments in the broader economy.
Latest
Nine of the largest pharma companies ink deals with Trump to lower drug prices
The agreements reduce prices on drugs that treat numerous costly and chronic conditions.
Merck and U.S. government partner to expand access to medicines and reduce costs for Americans
The company has committed more than $70 billion in U.S. investments to boost domestic production and innovation.
Google Trends looks at 2026 wellness shifts
Google Trends analysis revealed that new types of health-related searches emerged in the second half of 2025 and will continue into next year.
CRN appoints 2026 board leaders amid supplement regulation pressure
The Council for Responsible Nutrition announced its 2026 Board of Directors as it gears up for increased regulation and legislation.